Citadel Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $3.5M | Sell |
|
|||||
|
2022
Q2 | $43.2M | Sell |
|
|||||
|
2022
Q1 | $68.1M | Buy |
|
|||||
|
2021
Q4 | $49.3M | Buy |
|
|||||
|
2021
Q3 | $890K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $44.7M | Buy |
|
|||||
|
2020
Q4 | $16.3M | Sell |
|
|||||
|
2020
Q3 | $37.3M | Buy |
|
|||||
|
2020
Q2 | $18.4M | Buy |
|
|||||
|
2020
Q1 | $9.64M | Buy |
|
|||||
|
2019
Q4 | $14.9M | Buy |
|
|||||
|
2019
Q3 | $626K | Sell |
|
|||||
|
2019
Q2 | $12M | Buy |
|
|||||
|
2019
Q1 | $10.5M | Buy |
|
|||||
|
2018
Q4 | $1.3M | Sell |
|
|||||
|
2018
Q3 | $2.67M | Buy |
|
|||||
|
2018
Q2 | $1.39M | Sell |
|
|||||
|
2018
Q1 | $2.41M | Sell |
|
|||||
|
2017
Q4 | $28.2M | Buy |
|
|||||
|
2017
Q3 | $8.28M | Sell |
|
|||||
|
2017
Q2 | $39.5M | Buy |
|
|||||
|
2017
Q1 | $30.9M | Buy |
|
|||||
|
2016
Q4 | $433K | Buy |
|
|||||
|
2016
Q3 | $648K | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|